Heranba Industries is currently trading at Rs. 378.40, up by 0.20 points or 0.05% from its previous closing of Rs. 378.20 on the BSE.
The scrip opened at Rs. 377.00 and has touched a high and low of Rs. 380.40 and Rs. 374.05 respectively. So far 5903 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 475.00 on 25-Jan-2023 and a 52 week low of Rs. 265.00 on 29-Mar-2023.
Last one week high and low of the scrip stood at Rs. 393.35 and Rs. 369.70 respectively. The current market cap of the company is Rs. 1514.11 crore.
The promoters holding in the company stood at 74.94%, while Institutions and Non-Institutions held 0.23% and 24.83% respectively.
Heranba Industries’ wholly owned subsidiary -- Mikusu India has acquired 104,499 equity shares (i.e 1.74% of the equity and voting share capital) of Daikaffil Chemicals India. As on date, the total holding of Mikusu India is 21,59,019 constituting 35.98% of the equity and voting share capital of the target company.
Heranba Industries is engaged in manufacturing process which mainly includes chemical reactions of ammonolysis, esterification, hydrolysis, condensation, favorski reaction, isomerisation, cyanation, friedel crafts, methoxylation, cyclisation and halogenation.
| Company Name | CMP |
|---|---|
| UPL | 644.80 |
| PI Industries | 2952.55 |
| Bayer CropScience | 4794.65 |
| Sharda Cropchem | 1057.70 |
| Sumitomo Chemical | 418.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: